279 related articles for article (PubMed ID: 31033193)
1. The formyl peptide fMLF primes platelet activation and augments thrombus formation.
Salamah MF; Ravishankar D; Vaiyapuri R; Moraes LA; Patel K; Perretti M; Gibbins JM; Vaiyapuri S
J Thromb Haemost; 2019 Jul; 17(7):1120-1133. PubMed ID: 31033193
[TBL] [Abstract][Full Text] [Related]
2. The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation.
Salamah MF; Ravishankar D; Kodji X; Moraes LA; Williams HF; Vallance TM; Albadawi DA; Vaiyapuri R; Watson K; Gibbins JM; Brain SD; Perretti M; Vaiyapuri S
Blood Adv; 2018 Nov; 2(21):2973-2985. PubMed ID: 30413433
[TBL] [Abstract][Full Text] [Related]
3. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
[TBL] [Abstract][Full Text] [Related]
5. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
Zhou C; Zhou Y; Wang J; Feng Y; Wang H; Xue J; Chen Y; Ye RD; Wang MW
Biochem J; 2013 Apr; 451(2):245-55. PubMed ID: 23373827
[TBL] [Abstract][Full Text] [Related]
6. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
[TBL] [Abstract][Full Text] [Related]
7. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
[TBL] [Abstract][Full Text] [Related]
8. Identification of oligomer proanthocyanidins (F2) isolated from grape seeds as a formyl peptide receptor 1 partial agonist.
Yang J; Wang Q; Zhao R; Sun B; Wang L; Hou Y; Li X; Wu C
Int Immunopharmacol; 2013 Apr; 15(4):756-63. PubMed ID: 23523627
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and characterization of fMLF-mimicking AApeptides.
Hu Y; Cheng N; Wu H; Kang S; Ye RD; Cai J
Chembiochem; 2014 Nov; 15(16):2420-6. PubMed ID: 25224835
[TBL] [Abstract][Full Text] [Related]
10. The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice.
Salamah MF; Vallance TM; Kodji X; Ravishankar D; Williams HF; Brain SD; Vaiyapuri S
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887440
[TBL] [Abstract][Full Text] [Related]
11. Agonist concentration-dependent changes in FPR1 conformation lead to biased signaling for selective activation of phagocyte functions.
Wang J; Ye RD
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201249119. PubMed ID: 35878025
[TBL] [Abstract][Full Text] [Related]
12. N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow.
Shin MK; Jang YH; Yoo HJ; Kang DW; Park MH; Kim MK; Song JH; Kim SD; Min G; You HK; Choi KY; Bae YS; Min do S
J Biol Chem; 2011 May; 286(19):17133-43. PubMed ID: 21372136
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
[TBL] [Abstract][Full Text] [Related]
14. Formyl Met-Leu-Phe-Stimulated FPR1 Phosphorylation in Plate-Adherent Human Neutrophils: Enhanced Proteolysis but Lack of Inhibition by Platelet-Activating Factor.
Jesaitis AJ; Gripentrog J; Voyich JM
J Immunol Res; 2018; 2018():3178970. PubMed ID: 29785402
[TBL] [Abstract][Full Text] [Related]
15. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.
Southgate EL; He RL; Gao JL; Murphy PM; Nanamori M; Ye RD
J Immunol; 2008 Jul; 181(2):1429-37. PubMed ID: 18606697
[TBL] [Abstract][Full Text] [Related]
16. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
[TBL] [Abstract][Full Text] [Related]
17. Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes.
Cui Y; Hou X; Chen J; Xie L; Yang L; Le Y
J Nutr; 2010 Feb; 140(2):377-81. PubMed ID: 20032476
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.
Gemperle C; Schmid M; Herova M; Marti-Jaun J; Wuest SJ; Loretz C; Hersberger M
PLoS One; 2012; 7(11):e50195. PubMed ID: 23185575
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
[TBL] [Abstract][Full Text] [Related]
20. FPR1: A critical gatekeeper of the heart and brain.
Zhangsun Z; Dong Y; Tang J; Jin Z; Lei W; Wang C; Cheng Y; Wang B; Yang Y; Zhao H
Pharmacol Res; 2024 Apr; 202():107125. PubMed ID: 38438091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
